Medicinal Products

Lynparza

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Lynparza
Active Substance olaparib
Prescription Medicinal product subject to medical prescription
Type of prescription ograničeni recept
Distribution Supply through pharmacies (community)
ATC Code L01XK01
Marketing status stavljeno u promet
Shortage status nema nestašice
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download

Packaging

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o riziku od medikacijskih pogrešaka zbog uvođenja novog farmaceutskog oblika lijeka Lynparza (olaparib) 29.11.2018 AstraZeneca d.o.o.
Back